Literature DB >> 27999136

Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model.

Hiroki Uchida1, Kuniyasu Niizuma1, Yoshihiro Kushida1, Shohei Wakao1, Teiji Tominaga1, Cesario V Borlongan2, Mari Dezawa2.   

Abstract

BACKGROUND AND
PURPOSE: Multilineage-differentiating stress-enduring (muse) cells are endogenous nontumorigenic stem cells with pluripotency harvestable as pluripotent marker SSEA-3+ cells from the bone marrow from cultured bone marrow-mesenchymal stem cells. After transplantation into neurological disease models, muse cells exert repair effects, but the exact mechanism remains inconclusive.
METHODS: We conducted mechanism-based experiments by transplanting serum/xeno-free cultured-human bone marrow-muse cells into the perilesion brain at 2 weeks after lacunar infarction in immunodeficient mice.
RESULTS: Approximately 28% of initially transplanted muse cells remained in the host brain at 8 weeks, spontaneously differentiated into cells expressing NeuN (≈62%), MAP2 (≈30%), and GST-pi (≈12%). Dextran tracing revealed connections between host neurons and muse cells at the lesioned motor cortex and the anterior horn. Muse cells extended neurites through the ipsilateral pyramidal tract, crossed to contralateral side, and reached to the pyramidal tract in the dorsal funiculus of spinal cord. Muse-transplanted stroke mice displayed significant recovery in cylinder tests, which was reverted by the human-selective diphtheria toxin. At 10 months post-transplantation, human-specific Alu sequence was detected only in the brain but not in other organs, with no evidence of tumor formation.
CONCLUSIONS: Transplantation at the delayed subacute phase showed muse cells differentiated into neural cells, facilitated neural reconstruction, improved functions, and displayed solid safety outcomes over prolonged graft maturation period, indicating their therapeutic potential for lacunar stroke.
© 2016 The Authors.

Entities:  

Keywords:  brain ischemia; cerebral infarction; regeneration; stem cells; stroke, lacunar

Mesh:

Year:  2016        PMID: 27999136      PMCID: PMC5262965          DOI: 10.1161/STROKEAHA.116.014950

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke.

Authors:  Makoto Hayase; Masaaki Kitada; Shohei Wakao; Yutaka Itokazu; Kazuhiko Nozaki; Nobuo Hashimoto; Yasushi Takagi; Mari Dezawa
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-13       Impact factor: 6.200

2.  Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.

Authors:  Shohei Wakao; Masaaki Kitada; Yasumasa Kuroda; Taeko Shigemoto; Dai Matsuse; Hideo Akashi; Yukihiro Tanimura; Kenichiro Tsuchiyama; Tomohiko Kikuchi; Makoto Goda; Tatsutoshi Nakahata; Yoshinori Fujiyoshi; Mari Dezawa
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

3.  Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers.

Authors:  Kahori Kinoshita; Shinichiro Kuno; Hisako Ishimine; Noriyuki Aoi; Kazuhide Mineda; Harunosuke Kato; Kentaro Doi; Koji Kanayama; Jingwei Feng; Takanobu Mashiko; Akira Kurisaki; Kotaro Yoshimura
Journal:  Stem Cells Transl Med       Date:  2015-01-05       Impact factor: 6.940

4.  Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.

Authors:  Valeria Battistella; Gabriel R de Freitas; Lea Mirian Barbosa da Fonseca; Daniel Mercante; Bianca Gutfilen; Regina C S Goldenberg; Juliana Vieira Dias; Tais H Kasai-Brunswick; Eduardo Wajnberg; Paulo Henrique Rosado-de-Castro; Soniza V Alves-Leon; Rosalia Mendez-Otero; Charles Andre
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

5.  Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration.

Authors:  C L Sudlow; C P Warlow
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

6.  Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine.

Authors:  Fumitaka Ogura; Shohei Wakao; Yasumasa Kuroda; Kenichiro Tsuchiyama; Mozhdeh Bagheri; Saleh Heneidi; Gregorio Chazenbalk; Setsuya Aiba; Mari Dezawa
Journal:  Stem Cells Dev       Date:  2014-01-17       Impact factor: 3.272

7.  Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients.

Authors:  D J Richel; H E Johnsen; J Canon; T Guillaume; M R Schaafsma; C Schenkeveld; S W Hansen; I McNiece; A J Gringeri; R Briddell; C Ewen; R Davies; J Freeman; S Miltenyi; M Symann
Journal:  Bone Marrow Transplant       Date:  2000-02       Impact factor: 5.483

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Experimental model of small subcortical infarcts in mice with long-lasting functional disabilities.

Authors:  Hiroki Uchida; Hiroyuki Sakata; Miki Fujimura; Kuniyasu Niizuma; Yoshihiro Kushida; Mari Dezawa; Teiji Tominaga
Journal:  Brain Res       Date:  2015-10-29       Impact factor: 3.252

Review 10.  Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury.

Authors:  A M Parr; C H Tator; A Keating
Journal:  Bone Marrow Transplant       Date:  2007-07-02       Impact factor: 5.483

View more
  25 in total

Review 1.  New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.

Authors:  Marcin Wysoczynski; Abdur Khan; Roberto Bolli
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

2.  Intravenous injection of human multilineage-differentiating stress-enduring cells alleviates mouse severe acute pancreatitis without immunosuppressants.

Authors:  Masahiko Fukase; Naoaki Sakata; Yoshihiro Kushida; Shohei Wakao; Michiaki Unno; Mari Dezawa
Journal:  Surg Today       Date:  2021-10-23       Impact factor: 2.549

3.  Rho-Kinase Inhibition Improves the Outcome of Focal Subcortical White Matter Lesions.

Authors:  Sanem A Aykan; Hongyu Xie; Yi Zheng; David Y Chung; Sreekanth Kura; James Han Lai; Taylan D Erdogan; Andreia Morais; Isra Tamim; Damla Yagmur; Hidehiro Ishikawa; Ken Arai; M Abbas Yaseen; David A Boas; Sava Sakadzic; Cenk Ayata
Journal:  Stroke       Date:  2022-06-03       Impact factor: 10.170

Review 4.  Serum-Free Cultures: Could They Be a Future Direction to Improve Neuronal Differentiation of Mesenchymal Stromal Cells?

Authors:  Giovanni Schepici; Agnese Gugliandolo; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

5.  The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.

Authors:  Masahiro Iseki; Masamichi Mizuma; Shohei Wakao; Yoshihiro Kushida; Katsuyoshi Kudo; Masahiko Fukase; Masaharu Ishida; Tomoyuki Ono; Mitsuhiro Shimura; Ichiro Ise; Yukie Suzuki; Teruko Sueta; Ryuta Asada; Shinobu Shimizu; Yoshiyuki Ueno; Mari Dezawa; Michiaki Unno
Journal:  Surg Today       Date:  2020-09-11       Impact factor: 2.549

6.  Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue.

Authors:  Eriko Toyoda; Masato Sato; Takumi Takahashi; Miki Maehara; Yoshihiko Nakamura; Genya Mitani; Tomonori Takagaki; Kosuke Hamahashi; Masahiko Watanabe
Journal:  Regen Ther       Date:  2018-11-20       Impact factor: 3.419

7.  Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy.

Authors:  Toshihiko Suzuki; Yoshiaki Sato; Yoshihiro Kushida; Masahiro Tsuji; Shohei Wakao; Kazuto Ueda; Kenji Imai; Yukako Iitani; Shinobu Shimizu; Hideki Hida; Takashi Temma; Shigeyoshi Saito; Hidehiro Iida; Masaaki Mizuno; Yoshiyuki Takahashi; Mari Dezawa; Cesar V Borlongan; Masahiro Hayakawa
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-22       Impact factor: 6.200

Review 8.  Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke.

Authors:  Chikako Nito; Satoshi Suda; Yuko Nitahara-Kasahara; Takashi Okada; Kazumi Kimura
Journal:  Biomedicines       Date:  2022-03-22

Review 9.  A Museum of Stem Cells Points to Muse Cells as Robust Transplantable Cells for Stroke: Review.

Authors:  You Jeong Park; Jeffrey Farooq; Justin Cho; Blaise Cozene; Bella Gonzales-Portillo; Nadia Sadanandan; Madeline Saft; Jea Young Lee; Cesar V Borlongan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Selective Proliferation of Highly Functional Adipose-Derived Stem Cells in Microgravity Culture with Stirred Microspheres.

Authors:  Takanobu Mashiko; Koji Kanayama; Natsumi Saito; Takako Shirado; Rintaro Asahi; Masanori Mori; Kotaro Yoshimura
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.